Monday 13 April 2026

The Pharma Letter Podcast — Episode 10 — Will decentralized clinical trials become the new standard?

Pharmaceutical
Simon Wentworth
10 February 2022
the-pharma-letter-podcast-episode-10

More on this story...

Pharmaceutical
How to conduct a Phase III program in a pandemic
4 March 2022
Biotechnology
The Pharma Letter Podcast — Episode 13 — Is there a data capture crisis in biotech?
5 April 2022
Pharmaceutical
Regulators seek to make decentralized trials easier in Europe
20 December 2022
Pharmaceutical
2023: A milestone year for clinical trials?
26 January 2023




More ones to watch >




Today's issue

Russia begins more active cancelling of tenders for drugs awaiting cheaper generics
Generics
Russia begins more active cancelling of tenders for drugs awaiting cheaper generics
13 April 2026
Pharmaceutical
Pioneering Lotte Bjerre Knudsen to leave Novo Nordisk
13 April 2026
Biotechnology
First GSK data for B7-H4-targeted ADC and Jemperli 4-year OS data
13 April 2026
Pharmaceutical
Swedish push to attract clinical trials
13 April 2026
Pharmaceutical
Lilly deepens Asia manufacturing push amid GLP-1 boom
13 April 2026
Pharmaceutical
NICE backs broader access for AstraZeneca’s Lokelma
13 April 2026
Biotechnology
OriCell Therapeutics closes $110 million pre-IPO financing
13 April 2026


Company Spotlight

Alligator Bioscience
A clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs with a focus on the CD40 receptor pathway for cancer treatment.


More Features in Pharmaceutical

Pioneering Lotte Bjerre Knudsen to leave Novo Nordisk
13 April 2026
Swedish push to attract clinical trials
13 April 2026
Lilly deepens Asia manufacturing push amid GLP-1 boom
13 April 2026
NICE backs broader access for AstraZeneca’s Lokelma
13 April 2026


Copyright © The Pharma Letter 2026

 |  Headless Content Management with Blaze